抗ミュラーリアンホルモン検査市場：製品、エンドユーザー、流通、用途別-2025～2030年世界予測

抗ミュラーリアンホルモン検査市場は、2023年に2億7,426万米ドルと評価され、2024年には3億541万米ドルに達すると予測され、CAGR 11.46％で成長し、2030年には5億8,648万米ドルに達すると予測されています。

抗ミュラーリアンホルモン（AMH）検査は、血液中のAMHレベルを測定し、卵巣予備能、受胎可能性、不妊治療計画に関する重要な洞察を記載しています。AMH検査の必要性は、不妊評価、閉経の予測、多嚢胞性卵巣症候群（PCOS）の診断、がん治療中の卵巣機能の評価への応用から生じる。最終用途の範囲には、主に不妊治療クリニック、研究所、病院、診断センターが含まれます。不妊症の有病率の上昇、生殖医療に対する意識の高まり、検査技術の進歩が市場成長の原動力となっています。個別化医療や、より広範な不妊治療計画の中でのAMH検査の統合に新たな機会が見られます。男性内分泌学や小児内分泌学においても、AMH検査の応用が拡大する可能性があります。主要推奨事項としては、アクセス性と精度を向上させるためのポイントオブケア検査キットなどの技術的進歩への投資、統合ソリューションのための不妊治療クリニックとの協力関係の模索などが挙げられます。

市場開拓に影響する限界としては、検査費用の高さ、新興国市場での認知度の低さ、検査解釈のばらつきなどが挙げられます。さらに、不妊治療をめぐる倫理的な懸念や規制上の課題も、市場の進展を妨げる可能性があります。これらに対抗するには、対象を絞った啓発キャンペーンや検査オプションの助成が有益となる可能性があります。技術革新は、迅速な結果を提供する費用対効果の高い検査法の開発や、生殖医療におけるより優れた予測分析のためのAIの活用に焦点を当てることができると考えられます。さらに、様々な病状における役割など、AMHの広範な適用性に関するバイオテクノロジー研究が新たな道を開く可能性があります。市場の性質は、北米と欧州が支配的でありながら、アジア太平洋では未開拓の大きな可能性を秘めた、地域格差のある競合情勢を示唆しています。市場関係者は、不妊診断の技術的側面と社会文化的側面の両方のバランスを取りながら、市場への浸透を強化し、これらの新興地域の需要に対応するために、戦略的パートナーシップを模索し、教育イニシアティブに投資することが奨励されます。

市場力学：急速に進化する抗ミュラーリアンホルモン検査市場の主要市場洞察を公開

抗ミュラーリアンホルモン検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の多嚢胞性卵巣症候群の有病率の上昇
  • 体外受精と卵子凍結手術数の増加
• 市場抑制要因
  • AMH検査に利用できる償還金の制限
• 市場機会
  • 抗ミュラーリアンホルモン検査技術の進歩
  • 生殖・不妊治療の健康に対する認識を高めるための政府の取り組み
• 市場課題
  • 抗ミュラーホルモン検査キットに関連する矛盾と誤った結果

ポーターのファイブフォース：抗ミュラーリアンホルモン検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：抗ミュラーリアンホルモン検査市場における外部からの影響の把握

外部マクロ環境要因は、抗ミュラーリアンホルモン検査市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：抗ミュラーリアンホルモン検査市場における競合情勢の把握

抗ミュラーリアンホルモン検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：抗ミュラーリアンホルモン検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、抗ミュラーリアンホルモン検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目セグメントを網羅した包括的な市場分析を提供しています。

1.市場の浸透度：産業主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 多嚢胞性卵巣症候群の有病率が世界中で上昇
    • 体外受精と卵子凍結手術の増加
  • 抑制要因
    • AMH検査の払い戻しは限定的
  • 機会
    • 抗ミュラーリアンホルモン検査技術の進歩
    • 生殖と不妊治療の健康に関する意識を高めるための政府の取り組み
  • 課題
    • 抗ミュラー管ホルモンキットに関連する矛盾と誤った結果
• 市場セグメンテーション分析
  • 製品：専門家の監督を得るためのPOCテストに対する消費者の好みが高まっている
  • エンドユーザー：正確で迅速な結果を得るために、商業ラボでのAMH検査キットの普及が進んでいる
  • 流通：オンラインチャネルでのAMH検査キットの入手可能性の向上
  • 用途：ヒトへの応用におけるAMH検査キットの重要な使用
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 抗ミュラーリアンホルモン検査市場：製品別

• イントロダクション
• POCテスト
• セルフチェックキット

第7章 抗ミュラーリアンホルモン検査市場：エンドユーザー別

• イントロダクション
• 商業ラボ
• 研究開発

第8章 抗ミュラーリアンホルモン検査市場：流通別

• イントロダクション
• オフラインチャネル
• オンラインチャネル

第9章 抗ミュラーリアンホルモン検査市場：用途別

• イントロダクション
• 人間
• 非ヒト霊長類

第10章 南北アメリカの抗ミュラーリアンホルモン検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋の抗ミュラーリアンホルモン検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの抗ミュラーリアンホルモン検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • Siemens Healthineersによる卵巣予備能評価のための新しいアッセイの採用
  • 更年期管理に革命をもたらすARUP LaboratoriesによるMenoCheckの採用
  • アクセシビリティの向上と早期検出のためのElecsys抗ミュラー管ホルモンプラス免疫測定法の登場
  • Fertillyによる革新的な在宅不妊検査で、抗ミュラー管ホルモン分析を通じて生殖の健康状態を理解
  • SD BiosensorとSJL PartnersによるMeridian Bioscienceの戦略的買収により成長と世界的影響力を強化
  • Randox Quality Control、生殖検査を強化する先進的Acusera AMHコントロールを導入

企業一覧

• Abbexa Limited
• Abcam PLC
• Ansh Labs LLC
• Athenese-Dx
• Beckman Coulter, Inc. by Danaher Corporation
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• bioMerieux S.A.
• BioVendor-Laboratorni Medicina A.S.
• Chengdu VACURE BIoTechnology Co., Ltd.
• CTK BIoTech, Inc.
• Cusabio Technology LLC
• Eagle Biosciences, Inc.
• Elabscience Bionovation Inc.
• Epitope Diagnostics, Inc.
• F. Hoffmann-La Roche Ltd.
• Fujirebio Europe N.V. by H.U. Group Holdings, Inc.
• Goldsite Diagnostics Inc.
• Healthy Human Labs Limited（Vitall）
• Kamiya Biomedical Company
• LifeSpan BioSciences, Inc.
• London Gynaecology Limited
• Meridian Bioscience, Inc.
• Monobind Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• Tosoh Corporation
• Vitrosens BIoTechnology Co., Ltd.

LIST OF FIGURES

• FIGURE 1. ANTI-MULLERIAN HORMONE TEST MARKET RESEARCH PROCESS
• FIGURE 2. ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD THOUSAND)
• FIGURE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 6. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 14. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 16. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 18. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
• FIGURE 22. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANTI-MULLERIAN HORMONE TEST MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, 2018-2030 (USD THOUSAND)
• TABLE 4. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 5. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 6. ANTI-MULLERIAN HORMONE TEST MARKET DYNAMICS
• TABLE 7. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 8. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY POC TESTING, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 9. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY SELF-CHECK KITS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 10. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 11. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COMMERCIAL LABS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 12. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 13. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 14. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY OFFLINE CHANNELS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 15. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 16. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 17. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 18. GLOBAL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY NON-HUMAN PRIMATE, BY REGION, 2018-2030 (USD THOUSAND)
• TABLE 19. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 20. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 21. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 22. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 23. AMERICAS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 24. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 25. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 26. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 27. ARGENTINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 28. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 29. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 30. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 31. BRAZIL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 32. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 33. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 34. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 35. CANADA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 36. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 37. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 38. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 39. MEXICO ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 40. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 41. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 42. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 43. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 44. UNITED STATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
• TABLE 45. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 46. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 47. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 48. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 49. ASIA-PACIFIC ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 50. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 51. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 52. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 53. AUSTRALIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 54. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 55. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 56. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 57. CHINA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 58. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 59. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 60. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 61. INDIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 62. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 63. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 64. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 65. INDONESIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 66. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 67. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 68. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 69. JAPAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 70. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 71. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 72. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 73. MALAYSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 74. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 75. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 76. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 77. PHILIPPINES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 78. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 79. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 80. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 81. SINGAPORE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 82. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 83. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 84. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 85. SOUTH KOREA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 86. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 87. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 88. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 89. TAIWAN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 90. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 91. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 92. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 93. THAILAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 94. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 95. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 96. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 97. VIETNAM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
• TABLE 103. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 104. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 105. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 106. DENMARK ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 107. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 108. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 109. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 110. EGYPT ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 111. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 112. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 113. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 114. FINLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 115. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 116. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 117. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 118. FRANCE ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 119. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 120. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 121. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 122. GERMANY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 123. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 124. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 125. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 126. ISRAEL ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 127. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 128. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 129. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 130. ITALY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 131. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 132. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 133. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 134. NETHERLANDS ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 135. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 136. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 137. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 138. NIGERIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 139. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 140. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 141. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 142. NORWAY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 143. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 144. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 145. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 146. POLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 147. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 148. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 149. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 150. QATAR ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 151. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 152. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 153. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 154. RUSSIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 155. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 156. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 157. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 158. SAUDI ARABIA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 159. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 160. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 161. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 162. SOUTH AFRICA ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 163. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 164. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 165. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 166. SPAIN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 167. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 168. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 169. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 170. SWEDEN ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 171. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 172. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 173. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 174. SWITZERLAND ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 175. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 176. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 177. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 178. TURKEY ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 179. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 180. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 181. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 182. UNITED ARAB EMIRATES ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 183. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
• TABLE 184. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
• TABLE 185. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD THOUSAND)
• TABLE 186. UNITED KINGDOM ANTI-MULLERIAN HORMONE TEST MARKET SIZE, BY USE, 2018-2030 (USD THOUSAND)
• TABLE 187. ANTI-MULLERIAN HORMONE TEST MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 188. ANTI-MULLERIAN HORMONE TEST MARKET, FPNV POSITIONING MATRIX, 2023

The Anti-Mullerian Hormone Test Market was valued at USD 274.26 million in 2023, expected to reach USD 305.41 million in 2024, and is projected to grow at a CAGR of 11.46%, to USD 586.48 million by 2030.

The Anti-Mullerian Hormone (AMH) Test measures the level of AMH in blood, offering vital insights into ovarian reserve, fertility potential, and planning fertility treatments. The necessity of AMH testing arises from its applications in fertility assessments, predicting menopause onset, diagnosing polycystic ovarian syndrome (PCOS), and evaluating ovarian function during cancer treatments. The end-use scope primarily includes fertility clinics, research laboratories, hospitals, and diagnostic centers. The rising prevalence of infertility, increasing awareness of reproductive health, and advancements in testing technologies drive the market growth. Emerging opportunities are seen in personalized medicine and the integration of AMH testing within broader fertility treatment plans. There is potential in expanding AMH test applications in male and pediatric endocrinology as well. Key recommendations include investing in technological advancements such as point-of-care testing kits to improve accessibility and accuracy, and exploring collaborations with fertility clinics for integrated solutions.

Limitations affecting market growth include the high cost of testing, limited awareness in developing regions, and variability in test interpretation. Moreover, ethical concerns surrounding fertility treatments and regulatory challenges might hinder market progress. To counteract these, targeted awareness campaigns and subsidized testing options may prove beneficial. Innovations could focus on developing cost-effective testing methods that provide rapid results, or leveraging AI for better predictive analytics in reproductive health. Furthermore, biotechnological research into AMH's broader applicability, such as its role in various medical conditions, could open new avenues. The market nature suggests a competitive landscape with regional disparities in adoption rates, dominated by North America and Europe but with significant untapped potential in Asia-Pacific. Market players are encouraged to explore strategic partnerships and invest in educational initiatives to enhance market penetration and address demand in these emerging regions, balancing both the technical and socio-cultural facets of fertility diagnostics.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anti-Mullerian Hormone Test Market

The Anti-Mullerian Hormone Test Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of polycystic ovary syndrome worldwide
  • Growing number of IVF and egg-freezing procedures
• Market Restraints
  • Limited reimbursements available for AMH tests
• Market Opportunities
  • Advancements in anti-Mullerian hormone test technology
  • Government initiatives for creating awareness associated with reproductive and infertility treatment health
• Market Challenges
  • Inconsistencies and false results associated with anti-Mullerian hormone kits

Porter's Five Forces: A Strategic Tool for Navigating the Anti-Mullerian Hormone Test Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anti-Mullerian Hormone Test Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anti-Mullerian Hormone Test Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anti-Mullerian Hormone Test Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anti-Mullerian Hormone Test Market

A detailed market share analysis in the Anti-Mullerian Hormone Test Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anti-Mullerian Hormone Test Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anti-Mullerian Hormone Test Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Anti-Mullerian Hormone Test Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam PLC, Ansh Labs LLC, Athenese-Dx, Beckman Coulter, Inc. by Danaher Corporation, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux S.A., BioVendor - Laboratorni Medicina A.S., Chengdu VACURE Biotechnology Co., Ltd., CTK Biotech, Inc., Cusabio Technology LLC, Eagle Biosciences, Inc., Elabscience Bionovation Inc., Epitope Diagnostics, Inc., F. Hoffmann-La Roche Ltd., Fujirebio Europe N.V. by H.U. Group Holdings, Inc., Goldsite Diagnostics Inc., Healthy Human Labs Limited (Vitall), Kamiya Biomedical Company, LifeSpan BioSciences, Inc., London Gynaecology Limited, Meridian Bioscience, Inc., Monobind Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tosoh Corporation, and Vitrosens Biotechnology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Anti-Mullerian Hormone Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across POC Testing and Self-check Kits.
• Based on End-User, market is studied across Commercial Labs and Research & development.
• Based on Distribution, market is studied across Offline Channels and Online Channels.
• Based on Use, market is studied across Human and Non-Human Primate.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of polycystic ovary syndrome worldwide
    • 5.1.1.2. Growing number of IVF and egg-freezing procedures
  • 5.1.2. Restraints
    • 5.1.2.1. Limited reimbursements available for AMH tests
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in anti-Mullerian hormone test technology
    • 5.1.3.2. Government initiatives for creating awareness associated with reproductive and infertility treatment health
  • 5.1.4. Challenges
    • 5.1.4.1. Inconsistencies and false results associated with anti-Mullerian hormone kits
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing consumer preference for POC testing to obtain professional oversight
  • 5.2.2. End-User: Rising penetration of AMH test kits in commercial labs for accurate and rapid results
  • 5.2.3. Distribution: Emerging availability of AMH testing kits on online channels
  • 5.2.4. Use: Significant usage of AMH testing kits for human applications
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Anti-Mullerian Hormone Test Market, by Product

• 6.1. Introduction
• 6.2. POC Testing
• 6.3. Self-check Kits

7. Anti-Mullerian Hormone Test Market, by End-User

• 7.1. Introduction
• 7.2. Commercial Labs
• 7.3. Research & development

8. Anti-Mullerian Hormone Test Market, by Distribution

• 8.1. Introduction
• 8.2. Offline Channels
• 8.3. Online Channels

9. Anti-Mullerian Hormone Test Market, by Use

• 9.1. Introduction
• 9.2. Human
• 9.3. Non-Human Primate

10. Americas Anti-Mullerian Hormone Test Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Anti-Mullerian Hormone Test Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Anti-Mullerian Hormone Test Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Introduction of Novel Assay by Siemens Healthineers' for Assessing Ovarian Reserve
  • 13.3.2. The Introduction of MenoCheck by ARUP Laboratories to Revolutionizing Menopausal Management
  • 13.3.3. The Advent of the Elecsys Anti-Mullerian Hormone Plus immunoassay for Enhanced Accessibility and Early Detection
  • 13.3.4. Innovative At-Home Fertility Test by Fertilly for Understanding Reproductive Health through Anti-Mullerian Hormone Analysis
  • 13.3.5. Strategic Acquisition of Meridian Bioscience by SD Biosensor and SJL Partners for Enhanced Growth and Global Impact
  • 13.3.6. Randox Quality Control Introduces Advanced Acusera AMH Control for Enhanced Reproductive Testing

Companies Mentioned

• 1. Abbexa Limited
• 2. Abcam PLC
• 3. Ansh Labs LLC
• 4. Athenese-Dx
• 5. Beckman Coulter, Inc. by Danaher Corporation
• 6. Bio-Rad Laboratories, Inc.
• 7. Bio-Techne Corporation
• 8. bioMerieux S.A.
• 9. BioVendor - Laboratorni Medicina A.S.
• 10. Chengdu VACURE Biotechnology Co., Ltd.
• 11. CTK Biotech, Inc.
• 12. Cusabio Technology LLC
• 13. Eagle Biosciences, Inc.
• 14. Elabscience Bionovation Inc.
• 15. Epitope Diagnostics, Inc.
• 16. F. Hoffmann-La Roche Ltd.
• 17. Fujirebio Europe N.V. by H.U. Group Holdings, Inc.
• 18. Goldsite Diagnostics Inc.
• 19. Healthy Human Labs Limited (Vitall)
• 20. Kamiya Biomedical Company
• 21. LifeSpan BioSciences, Inc.
• 22. London Gynaecology Limited
• 23. Meridian Bioscience, Inc.
• 24. Monobind Inc.
• 25. Siemens Healthineers AG
• 26. Thermo Fisher Scientific Inc.
• 27. Tosoh Corporation
• 28. Vitrosens Biotechnology Co., Ltd.